tradit
pathogen
detect
method
public
health
infecti
diseas
surveil
reli
upon
identif
agent
alreadi
known
associ
particular
clinic
syndrom
emerg
field
metagenom
potenti
revolution
pathogen
detect
public
health
laboratori
allow
simultan
detect
microorgan
clinic
sampl
without
priori
knowledg
ident
use
nextgener
dna
sequenc
singl
metagenom
analysi
potenti
detect
rare
novel
pathogen
uncov
role
dysbiot
microbiom
infecti
chronic
human
diseas
make
use
advanc
sequenc
platform
bioinformat
tool
recent
studi
shown
metagenom
even
determin
wholegenom
sequenc
pathogen
allow
infer
antibiot
resist
virul
evolut
transmiss
made
enter
era
novel
infecti
diseas
identifi
metagenomicsbas
method
tradit
laboratori
method
impetu
public
health
laboratori
integr
metagenom
techniqu
diagnost
arsen
tradit
pathogen
detect
method
public
health
infecti
diseas
surveil
reli
upon
identif
agent
alreadi
known
associ
particular
clinic
syndrom
emerg
field
metagenom
potenti
revolution
pathogen
detect
public
health
laboratori
allow
simultan
detect
microorgan
clinic
sampl
without
priori
knowledg
ident
use
nextgener
dna
sequenc
singl
metagenom
analysi
potenti
detect
rare
novel
pathogen
uncov
role
dysbiot
microbiom
infecti
chronic
human
diseas
make
use
advanc
sequenc
platform
bioinformat
tool
recent
studi
shown
metagenom
even
determin
wholegenom
sequenc
pathogen
allow
infer
antibiot
resist
virul
evolut
transmiss
made
enter
era
novel
infecti
diseas
identifi
metagenomicsbas
method
tradit
laboratori
method
impetu
public
health
laboratori
integr
metagenom
techniqu
diagnost
arsen
public
health
infecti
diseas
surveil
employ
two
strategi
detect
case
outbreak
communic
diseas
laboratorybas
surveil
syndrom
surveil
reli
nonlaboratori
data
although
syndrom
surveil
sometim
viabl
option
populationlevel
monitor
certain
diseas
laboratorybas
surveil
usual
accur
definit
diagnosi
infecti
diseas
requir
laboratori
confirm
rang
method
avail
public
health
laboratori
tradit
assay
includ
microscopi
culturebas
analys
well
immunoassay
detect
antigen
pathogen
immun
respons
host
modern
techniqu
includ
nucleic
acid
amplif
test
nevertheless
mani
sampl
enter
public
health
laboratori
remain
undiagnos
despit
subject
batteri
convent
laboratori
test
convent
laboratori
assay
fail
detect
caus
agent
approxim
gastroenter
mani
enceph
case
complic
surveil
diseas
presum
pathogen
agent
present
sampl
undetect
diseas
agent
case
may
simpli
known
speci
target
laboratori
test
algorithm
may
truli
novel
pathogen
emerg
novel
microorgan
challeng
laboratori
surveil
effort
must
constantli
evolv
identifi
new
pathogen
middl
east
respiratori
syndrom
coronaviru
merscov
influenza
emerg
pathogen
zoonot
origin
entri
human
popul
facilit
human
encroach
previous
uninhabit
region
vector
redistribut
result
habitat
loss
climat
chang
one
potenti
way
improv
laboratori
surveil
would
employ
molecular
method
analyt
algorithm
pathogenagnost
metagenom
cultureindepend
sequenc
analysi
nucleic
acid
recov
sampl
potenti
revolution
detect
known
novel
microorgan
holist
natur
mean
instead
perform
multipl
target
assay
look
specif
pathogen
laboratori
use
singl
sequencingbas
test
capabl
identifi
microorgan
sampl
without
need
cultur
furthermor
use
sequenc
technolog
permit
assembl
complet
nearcomplet
genom
pathogen
sampl
sequenc
data
use
predict
antibiot
resist
phenotyp
identifi
virul
gene
inform
enhanc
outbreak
investig
recent
year
metagenom
proven
use
investig
novel
speci
strain
outbreak
complex
diseas
nextgener
sequenc
technolog
improv
cost
continu
drop
anticip
metagenom
approach
infecti
diseas
investig
becom
increasingli
common
public
health
laboratori
particularli
given
recent
technic
improv
mean
metagenom
detect
pathogen
low
abund
perform
directli
clinic
sampl
even
singl
cell
review
explor
metagenom
approach
public
health
laboratori
perspect
begin
descript
two
metagenom
approach
util
pathogen
detect
discuss
implement
metagenom
approach
public
health
set
cover
challeng
still
need
address
diagnost
sensit
comput
resourc
ascertain
causat
tradit
laboratori
method
pathogen
detect
tradit
paradigm
diagnost
microbiolog
reli
upon
test
tailor
etiolog
agent
definit
associ
specif
syndrom
refer
laboratori
current
employ
panel
laboratori
assay
includ
cultur
microscopi
serolog
pcr
tool
power
method
identifi
microb
respect
cultur
condit
microscop
sensit
serolog
reagent
pcr
primer
compat
microbi
target
specimen
type
convent
test
fail
identifi
microbi
pathogen
sampl
enhanc
molecular
approach
use
pcrbase
analys
design
captur
wider
array
target
employ
includ
singl
multiplex
pcr
assay
conserv
region
within
speci
genu
differenti
label
nucleic
acid
probe
direct
sequenc
pcr
product
comput
analys
use
identifi
conserv
region
genom
known
speci
genu
member
region
chosen
primer
probe
target
multiplex
assay
region
multipl
target
select
detect
common
pathogen
known
associ
clinic
syndrom
consensu
pcr
use
degener
primer
also
use
success
identifi
larg
varieti
bacteria
virus
variou
host
environ
includ
recent
emerg
merscov
go
metagenom
approach
pathogen
detect
convent
enhanc
molecular
test
fail
identifi
caus
agent
sampl
culturefre
holist
metagenom
approach
might
provid
answer
metagenom
studi
human
environment
microbiolog
public
health
metagenom
take
one
two
form
first
target
strategi
call
deep
amplicon
sequenc
da
employ
presequenc
pcr
amplif
step
amplifi
select
taxonom
marker
rrna
gene
second
broader
strategi
known
shotgun
metagenom
total
nucleic
acid
content
sampl
sequenc
either
directli
appli
enrich
step
might
capturebas
approach
subtract
prior
sequenc
tabl
benefit
disadvantag
method
group
adopt
parallel
approach
techniqu
appli
sampl
interest
within
given
taxonom
group
certain
gene
famili
occur
everi
known
member
speci
human
microbiom
project
hmp
along
mani
environment
microbiom
studi
investig
variou
microbi
commun
use
pcr
primer
target
conserv
gene
famili
design
pcr
primer
amplifi
region
within
gene
research
gener
pcr
product
call
amplicon
dna
sequenc
amplicon
specif
differ
microbi
speci
allow
identif
variou
member
microbi
commun
use
nextgenerationbas
deep
sequenc
mani
differ
amplicon
sampl
sequenc
result
sequenc
compar
refer
databas
conserv
gene
identifi
speci
andor
genu
associ
sequenc
da
techniqu
capabl
identifi
novel
microorgan
describ
microbiom
specimen
quantifi
abund
variou
taxa
sampl
tabl
bacteri
da
strategi
typic
util
primer
specif
conserv
gene
rrna
also
name
heat
shock
groel
rna
polymeras
rpob
similarli
protozoan
fungal
da
studi
often
target
conserv
rrna
gene
region
extraordinari
genom
divers
virus
preclud
amplif
univers
conserv
gene
abil
take
complet
viral
censu
sampl
howev
primer
specif
larg
phylogenet
group
picornalik
viru
superfamili
enabl
largescal
viral
da
studi
previous
uncharacter
viral
popul
tabl
respect
pathogen
detect
pcr
amplif
step
inher
da
protocol
increas
assay
sensit
microorgan
target
potenti
allow
higher
resolut
confid
identif
strain
speci
despit
util
detect
otherwis
unidentifi
organ
howev
potenti
bias
pcr
amplif
variabl
copi
number
target
gene
caus
da
gener
artifici
inflat
count
certain
taxa
sampl
furthermor
univers
primer
use
da
might
truli
univers
potenti
caus
certain
speci
even
group
speci
miss
thu
da
give
inaccur
estim
microbi
commun
composit
given
da
introduc
inher
bia
pathogen
detect
requir
priori
knowledg
potenti
pathogen
agent
interest
order
select
appropri
gene
amplif
unbias
sequenceindepend
shotgun
metagenom
approach
better
suit
task
identifi
unknown
organ
sampl
interest
character
healthi
human
gut
microbiom
hmp
potenti
higher
sensit
target
gene
may
truli
univers
determin
taxonom
relationship
ancient
gut
microbiom
found
similar
modern
rural
modern
cosmopolitan
microbiom
less
expens
fewer
read
requir
taxonom
classif
primer
bia
may
alter
popul
structur
rpob
archaeal
bacteri
identif
use
divid
speci
gardnerella
vaginali
subgroup
rpob
offer
enhanc
taxonom
resolut
compar
rrna
possibl
variabl
gene
copi
number
amongst
target
speci
recoveri
sequenc
microorgan
broad
specif
might
decreas
sensit
detect
unexpect
microb
stool
sampl
priori
knowledg
microorgan
requir
librari
prepar
rel
labor
intens
subtract
function
taxonom
character
identifi
diverg
region
noncod
rna
listeria
monocytogen
random
primer
reduc
potenti
bia
bioinformat
analysi
challeng
associ
fusobacterium
nucleatum
colorect
carcinoma
rel
expens
read
requir
da
novel
viru
discoveri
detect
novel
influenza
nasopharyng
swab
approxim
sequenc
gener
signific
homolog
known
protein
databas
dark
matter
detect
novel
rhabdoviru
serum
hybrid
captur
investig
sequenc
low
copi
number
metagenom
analysi
tuberculosi
mummi
increas
granular
popul
structur
determin
investig
yersinia
pesti
ancient
teeth
specif
primer
need
made
discrimin
group
rdrp
rnadepend
rna
polymeras
contrast
approach
taken
da
leverag
conserv
gene
famili
across
bacteria
fungi
protist
virus
shotgun
metagenom
potenti
catalogu
microb
present
sampl
irrespect
kingdom
origin
sequenc
nucleic
acid
extract
specimen
extract
materi
sequenc
nextgener
sequenc
platform
result
read
compar
refer
databas
databas
much
larger
use
da
must
contain
known
sequenc
organ
rather
set
sequenc
singl
gene
famili
although
make
analyt
part
shotgun
studi
comput
intens
advantag
da
numer
shotgun
method
less
bias
gener
data
better
reflect
sampl
true
popul
structur
recent
shown
hmp
team
furthermor
shotgun
method
interrog
accessori
genom
noncor
set
gene
often
differenti
pathogen
bacteria
within
genu
speci
close
relat
commens
strain
exampl
escherichia
coli
strain
ident
rrna
da
analysi
yet
latter
strain
consider
virul
shotgun
metagenom
studi
sometim
follow
sanger
sequenc
gener
complet
finish
genom
novel
virus
identifi
sever
novel
pathogen
clinic
sampl
tabl
recent
notabl
discoveri
bascongo
viru
rhabdoviru
associ
hemorrhag
fever
outbreak
african
congo
metagenomebas
detect
subsequ
de
novo
assembl
fulllength
viru
genom
novel
rhabdoviru
shown
share
amino
acid
ident
closest
known
rel
exampl
novel
pathogen
discov
metagenom
includ
previous
unknown
cyclovirus
found
cerebrospin
fluid
patient
paraplegia
unknown
etiolog
uniqu
hybrid
circoparvoviru
nihcqv
seroneg
hepat
patient
given
advantag
shotgun
metagenom
da
pathogen
detect
former
becom
increasingli
promin
public
health
laboratori
set
laboratori
must
adapt
new
technic
challeng
present
techniqu
includ
prepar
sampl
sequenc
librari
sequenc
bioinformat
analysi
although
metagenom
studi
opt
sequenc
nucleic
acid
extract
sampl
regardless
origin
other
adopt
focus
strategi
select
popul
microorgan
bacteria
virus
specif
nucleic
acid
popul
dna
rna
target
case
sampl
prepar
pipelin
must
modifi
target
specif
group
interest
virusspecif
metagenom
studi
cellular
materi
first
remov
use
filtrat
centrifug
maxim
recoveri
virion
enzymat
treatment
sampl
nucleas
enrich
viral
nucleic
acid
remov
nonvir
nucleic
acid
viral
nucleic
acid
remain
protect
within
nucleocapsid
figur
second
technic
issu
microbi
fraction
nucleic
acid
clinic
sampl
extrem
small
dna
present
often
human
origin
human
dna
remov
prior
postdna
sequenc
use
laboratori
bioinformat
method
respect
human
dna
remov
use
laboratori
method
small
amount
microbi
nucleic
acid
remain
requir
newer
techniqu
sequenc
librari
construct
gener
usabl
dna
librari
librari
prepar
kit
nextera
xt
illumina
san
diego
ca
usa
requir
one
nanogram
input
dna
nextera
xt
recent
use
metagenom
character
pathogen
german
shigatoxigen
e
coli
outbreak
aid
detect
microorgan
sampl
low
level
nucleic
acid
nucleic
acid
present
low
concentr
higher
sequenc
depth
might
also
necessari
uncov
rare
sequenc
laboratori
protocol
implement
sequenc
directli
clinic
sampl
low
nucleic
acid
concentr
includ
random
pcr
well
multipl
displac
amplif
mda
recent
exampl
mclean
et
al
coupl
fluorescenceactiv
cell
sort
fac
mda
singlecel
genom
analys
microbi
commun
biofilm
hospit
sink
incorpor
mda
also
avoid
introduct
mutat
singl
cell
approach
may
result
cultur
individu
sort
bacteri
cell
follow
nucleic
acid
extract
librari
prepar
figur
dna
sequenc
perform
multipl
nextgener
sequenc
platform
avail
platform
depend
sampl
sequenc
question
ask
laboratori
budget
capac
increas
number
public
health
laboratori
acquir
benchtop
sequenc
machin
illumina
miseq
ion
torrent
pgm
small
afford
ideal
suit
microbi
work
laboratori
outsourc
sampl
larger
sequenc
center
follow
sequenc
hundr
thousand
million
short
read
gener
must
comput
transform
meaning
data
reflect
presenc
abund
microb
interest
bioinformat
analysi
often
perform
use
stage
approach
outlin
figur
public
health
laboratori
work
metagenom
must
suffici
comput
power
analyt
expertis
execut
step
may
requir
hire
experienc
bioinformatician
design
inhous
data
analysi
pipelin
comput
pipelin
typic
begin
remov
sequenc
librari
adapt
filter
lowqual
sequenc
although
step
sometim
handl
softwar
embed
dna
sequenc
clinic
sampl
human
origin
humanderiv
sequenc
read
compris
major
data
gener
sequenc
necessari
remov
human
read
often
compar
read
human
refer
genom
discard
map
human
genom
read
remain
filter
directli
compar
microbi
refer
sequenc
databas
assembl
de
novo
larger
cluster
contigu
sequenc
read
contig
compar
refer
sequenc
databas
often
two
approach
use
sequenti
figur
first
individu
read
compar
refer
databas
order
assign
mani
read
possibl
speci
genu
phylum
origin
databas
use
referencebas
assembl
well
paramet
use
call
match
must
chosen
care
larg
impact
assembl
gener
time
taken
gener
larg
databas
increas
chanc
find
match
significantli
increas
analysi
time
similarli
permiss
paramet
might
enabl
identif
speci
diverg
refer
organ
may
also
lead
incorrect
taxonom
assign
thu
referencebas
assembl
also
perform
stage
increas
databas
size
decreas
stringenc
next
remain
read
map
microbi
sequenc
assembl
de
novo
often
use
specif
algorithm
develop
metagenom
assembl
taxonom
assign
contig
gener
algorithm
capabl
identifi
distant
taxonom
match
must
use
altern
strategi
identifi
novel
sequenc
read
use
pairedend
inform
increas
iter
size
contig
known
classif
recent
develop
success
implement
identifi
two
novel
arenavirus
snake
current
public
health
infecti
diseas
surveil
requir
priori
knowledg
pathogen
interest
must
valid
test
pathogen
must
includ
laboratori
test
portfolio
approach
often
detect
emerg
complet
novel
pathogen
pathogen
known
present
given
region
unknown
unusu
infecti
diseas
syndrom
encount
patient
specimen
serial
test
list
known
suspect
pathogen
figur
nevertheless
convent
laboratori
test
might
remain
neg
even
multipl
sampl
collect
multipl
test
conduct
point
investig
pathogenagnost
method
metagenom
deploy
result
help
uncov
unknown
etiolog
agent
inform
develop
new
laboratori
diagnost
test
test
algorithm
detect
futur
instanc
pathogen
question
sever
exampl
instanc
metagenom
approach
abl
detect
pathogen
miss
tradit
techniqu
tabl
includ
scenario
pathogen
present
low
level
sampl
suspect
pathogen
true
caus
detect
test
use
causal
agent
either
distantli
relat
variant
suspect
pathogen
see
figur
previou
page
figur
workflow
outlin
pipelin
laboratori
bioinformat
method
requir
metagenom
pathogen
detect
left
side
pale
blue
list
step
metagenom
workflow
right
side
list
tool
use
stage
box
right
colorcod
indic
type
tool
use
dark
blue
laboratori
method
gray
data
format
green
comput
softwar
maroon
databas
bwa
burrowswheel
align
blast
basic
local
align
search
tool
img
integr
microbi
genom
mgrast
metagenom
rapid
annot
server
entir
new
speci
exampl
metagenom
abl
detect
pathogen
miss
reason
studi
condyloma
sampl
neg
human
papillomaviru
hpv
pcr
metagenom
detect
hpv
type
put
novel
hpv
type
well
molluscum
contagiosum
viru
mcv
would
gone
undetect
use
convent
techniqu
beyond
pathogen
detect
mani
shotgun
metagenom
studi
success
gener
complet
nearli
complet
pathogen
genom
assembl
sampl
allow
comprehens
character
microb
question
multipl
level
assembl
might
allow
predict
microbi
phenotyp
indic
presenc
absenc
antimicrobi
resist
virul
gene
also
use
calcul
microbi
genotyp
use
silico
techniqu
concert
epidemiolog
inform
identifi
persontoperson
transmiss
event
outbreak
epidem
dynam
case
function
profil
metagenom
offer
signific
advantag
replac
multipl
test
singl
analysi
figur
although
must
note
alway
possibl
detect
speci
within
metagenom
particular
gene
come
rather
singl
etiolog
agent
particular
combin
speci
within
individu
sometim
caus
diseas
mixtur
da
shotgun
metagenom
hmp
character
healthi
microbiom
individu
collect
microbi
nucleic
acid
bodi
habitat
five
site
oral
nasal
skin
gut
urogenit
compar
microbi
divers
site
across
individu
hmp
demonstr
healthi
human
microbiom
differ
significantli
taxonom
composit
individu
bodi
site
microbi
metabol
pathway
site
remain
stabl
publichealth
len
metagenom
thu
provid
opportun
compar
taxonom
function
differ
microb
present
healthi
individu
rang
condit
acut
infect
chronic
diseas
known
unknown
etiolog
metagenom
studi
employ
casecontrol
associ
discoveri
approach
identifi
associ
inflammatori
bowel
diseas
enterobacteriacea
colorect
carcinoma
fusobacterium
type
diabet
butyrateproduc
bacteria
howev
studi
design
requir
care
match
characterist
includ
age
gender
ethnic
underli
comorbid
across
case
control
associ
identifi
must
verifi
addit
sampl
two
recent
studi
investig
metagenom
associ
type
diabet
highlight
difficulti
studi
use
two
popul
one
mix
gender
china
elderli
european
femal
although
popul
demonstr
associ
butyrateproduc
bacteria
type
diabet
discriminatori
characterist
differ
two
group
classif
gener
one
sampl
set
use
predict
power
much
reduc
despit
difficulti
associ
studi
provid
valuabl
inform
natur
dysbiot
microbiom
disrupt
membership
function
capac
healthi
microbiom
alter
state
could
result
pathogen
speci
chang
abund
distribut
microbi
commun
member
could
caus
iatrogen
intervent
antibiot
treatment
understand
dysbiosi
role
diseas
open
door
develop
altern
form
treatment
probiot
stool
transplant
effect
treat
clostridium
difficil
infect
beyond
profil
bacteri
viral
microbiom
fungal
compon
human
microbiom
mycobiom
emerg
field
akin
earli
bacteriolog
da
studi
cultur
fungal
speci
associ
ill
studi
detail
recent
target
da
rrna
reveal
speci
divers
endogen
fungal
commun
richer
previous
assum
furthermor
mycobiom
uniqu
human
divers
fungal
popul
also
recov
varieti
mammal
impact
mycobiom
human
health
diseas
current
unknown
addit
investig
use
metagenom
approach
requir
character
mycobiom
potenti
public
health
impact
figur
strategi
novel
pathogen
detect
public
health
current
specimen
sent
convent
laboratori
test
one
test
posit
dash
arrow
action
result
gener
neg
investig
method
metagenom
employ
afterward
white
arrow
advanc
metagenom
method
may
perform
earlier
diagnost
algorithm
futur
black
arrow
instead
follow
multipl
tradit
laboratori
test
addit
identifi
unknown
novel
pathogen
character
normal
diseaseassoci
microbi
commun
metagenom
also
advantag
character
microbiom
environ
relev
public
health
hospit
healthcar
facil
previou
nonmetagenom
studi
look
presenc
specif
pathogen
healthcar
environ
metagenom
profil
environ
allow
simultan
detect
multipl
pathogen
exampl
singl
metagenom
studi
abl
identifi
candid
speci
biofilm
hospit
sink
includ
identif
new
bacteri
phylum
metagenom
investig
healthcar
environ
promis
provid
import
insight
microbi
ecolog
dynam
set
hospit
clinic
focu
recent
hospit
microbiom
project
aim
investig
interact
microbiom
patient
surround
hospit
environ
stand
way
challeng
face
metagenom
public
health
despit
success
describ
applic
metagenom
laboratorybas
diagnost
still
infanc
tabl
recent
studi
use
metagenom
investig
diarrhea
sampl
posit
shigatoxigen
e
coli
show
sensit
compar
cultur
impli
advanc
necessari
metagenom
replac
tradit
culturebas
molecular
diagnost
howev
studi
demonstr
metagenom
util
identifi
unknown
unknown
author
abl
identifi
coinfect
detect
convent
test
moment
metagenom
proven
use
detect
novel
microorgan
discov
novel
pathogen
unusu
collect
microorgan
within
clinic
sampl
howev
mere
first
step
process
determin
role
diseas
identif
microbi
speci
genom
alon
establish
causat
fact
mani
pathogen
discov
approach
fail
meet
koch
postul
causal
sometim
possibl
cultur
pathogen
identifi
suitabl
anim
model
studi
confront
challeng
sever
group
suggest
altern
koch
postul
introduct
pcrand
dnabas
identif
method
frederick
relman
suggest
modifi
postul
even
might
adequ
recogn
complex
diseas
combin
multipl
possibl
perform
metagenom
studi
singl
cell
bias
cultur
method
may
point
wrong
pathogen
genom
assembl
organ
rel
nucleic
acid
abund
low
earli
identif
novel
pathogen
vital
prevent
potenti
outbreak
may
identifi
pathogen
unknown
diverg
known
organ
de
novo
assembl
allow
gener
genom
sequenc
novel
pathogen
detect
transmiss
microorgan
andor
environment
factor
requir
caus
diseas
recent
set
postul
applic
metagenom
suggest
even
requir
inocul
host
may
possibl
pathogen
evid
serolog
epidemiolog
analys
abil
stop
diseas
microorganismspecif
drug
antibodi
also
use
address
difficulti
meet
koch
postul
ubiquit
virus
exampl
epsteinbarr
viru
human
herp
viru
torqu
teno
viru
diseas
addit
variabl
host
genet
environment
factor
play
signific
role
howev
proof
causal
exceedingli
difficult
circumst
care
must
taken
creat
spuriou
link
infecti
agent
diseas
sinc
fals
associ
could
lead
potenti
danger
treatment
might
harder
disprov
gener
initi
complex
diseas
polymicrobi
etiolog
metagenom
provid
foundat
target
quantit
analys
larger
cohort
order
differenti
microorgan
drive
diseas
nonpathogen
commens
interpret
result
metagenom
studi
also
import
balanc
scientif
plausibl
research
find
like
true
prior
probabl
find
high
thu
unusu
metagenom
result
addit
line
evid
requir
confirm
exampl
studi
nasopharyng
swab
taken
individu
pandem
one
sampl
contain
pair
read
map
nucleotid
ident
ebola
viru
investig
find
conclud
contamin
sinc
shotgun
metagenom
rel
new
field
possibl
caus
contamin
yet
known
includ
experiment
reagent
dna
extract
column
crosscontamin
sampl
process
carryov
sequenc
run
despit
caveat
new
discoveri
must
initi
aris
novel
unexpect
find
must
follow
appropri
control
sampl
experi
although
metagenom
predat
nextgener
sequenc
current
sequenc
technolog
transform
emerg
field
enabl
comprehens
character
microb
sampl
metagenom
approach
matur
method
clinic
valid
metagenomicsbas
approach
might
becom
frontlin
diagnost
test
infecti
diseas
public
health
set
face
unknown
complex
infecti
diseas
multipl
convent
diagnost
test
often
use
potenti
lead
unnecessari
cost
delay
diagnosi
instead
metagenom
might
use
singl
comprehens
screen
test
potenti
pathogen
known
novel
well
assess
state
individu
microbiom
figur
addit
target
diagnost
test
could
use
understand
clinic
diseas
determin
manag
option
sequenc
becom
cheaper
faster
becom
possibl
serial
character
human
microbiom
investig
chang
time
could
lead
person
medicin
infecti
diseas
account
host
genom
microbiom
person
treatment
use
narrowspectrum
antibiot
reduc
disrupt
microbiom
specif
probiot
restor
individu
microbiom
healthi
state
similar
procedur
could
also
appli
environment
microbiom
healthcar
set
exampl
urinari
cathet
could
treat
prebiot
reduc
risk
colon
harm
bacteria
fact
suggest
metagenom
investig
microbiom
could
becom
standard
dna
sequenc
could
use
household
toilet
monitor
chang
stool
microbiom
content
could
use
guid
intervent
maintain
health
pathogen
interest
known
current
metagenom
approach
limit
sensit
compar
tradit
techniqu
pathogen
detect
thu
although
metagenom
might
one
day
use
screen
clinic
sampl
current
best
posit
complementari
techniqu
use
alongsid
cultur
tradit
method
greatest
valu
metagenom
clinic
case
convent
techniqu
fail
find
microbi
caus
even
metagenom
requir
skill
scientist
perform
experi
analyz
data
thu
date
exercis
primarili
realm
academ
research
rather
frontlin
public
health
consid
bona
fide
clinic
test
pathogen
detect
public
health
laboratori
standard
metagenom
protocol
necessari
test
analyz
sampl
interlaboratori
comparison
result
wholegenom
sequenc
technolog
decreas
price
increas
speed
simplic
howev
expect
metagenom
approach
appli
often
public
health
emerg
routin
pipelin
like
evolv
ongo
collabor
research
clinician
forward
step
crucial
increas
arsen
tool
public
health
thu
allow
us
rapidli
detect
manag
novel
emerg
infecti
diseas
